Autoimmunity and tumor immunity induced by immune responses to mutations in self. - Wikidata - wikimedia - TriplyDB

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

http://www.wikidata.org/entity/Q46917393

about

Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications Granzyme B cleavage of autoantigens in autoimmunity New perspectives on the role of vitiligo in immune responses to melanoma Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity Display technologies: application for the discovery of drug and gene delivery agents.Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.Coherent somatic mutation in autoimmune disease.On the definition of a criterion of immunogenicity.TCR recognition of peptide/MHC class II complexes and superantigens Development of effective vaccines for old mice in a tumor model.Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice.Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma Targeting c-MYC with T-cells Mechanisms of immunization against cancer using chimeric antigens.Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells.Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Tumor infection by oncolytic reovirus primes adaptive antitumor immunity.Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients.Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI).Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity.Activated monocytes prime naïve T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo.Association of the autoimmune disease scleroderma with an immunologic response to cancer.HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.Immune response to mutant neo-antigens: Cancer's lessons for aging.Conceptual aspects of self and nonself discrimination.Immune rejection of mouse tumors expressing mutated self.Is Tolerance Broken in Autoimmunity?Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT.

P2860

Q24605267-EB0633DB-B1D9-4B7D-A3BB-1F9B1343A96E Q24633095-730451FB-A307-4566-83D9-EF6F9D8333C5 Q26996799-07EA97B6-D0B6-4279-9B73-33CE9D1930A9 Q27643966-416BB63E-8E17-49EE-9AF2-BC69CA2F792A Q28749317-9461B095-CA4B-4B7E-B5F1-CDB0BFC19CE4 Q33264491-3EADFFD2-506B-4713-AA4A-1891089A50F3 Q33730129-7C8A3D24-17F7-4336-9849-D9DCA0D9E2CF Q33837769-0FB455F1-D611-4A8B-A0C9-2DB6B977DD78 Q34000887-B9241329-FF11-4ED9-B439-494F57BC983D Q34171867-9F8FE96A-3152-4568-99C2-8252FE3CABC6 Q34501086-A4E04354-9853-4123-81E3-0E4F60547CE5 Q34625208-747012E5-CAD2-4204-8AF8-FE4B4B4A9BAF Q34801323-AA76EE96-6597-4143-9D98-625C5B3ED734 Q34876334-B89BFCDC-0082-4AA9-871C-864626F23143 Q35018846-663719A3-23A9-419A-B6C9-A6B5C4514177 Q35442846-D5199D99-E6CF-4F2E-AB24-EE6734633C92 Q35498335-1F4904E4-204C-4929-BD08-DD82B2868DD4 Q36229067-A176CC31-E410-4129-A0A5-3FC2A2494A01 Q36821263-B1B83E4F-8E2F-4A9B-8E93-51A5F5B1E8B3 Q36976664-ACE15A8F-5CDF-4C74-8477-2F3252380AD2 Q37100759-B9CF7B49-D4A3-4885-B7B3-000B9E9B3397 Q37123441-EE87D696-E944-4D36-A225-BAE353A6DD53 Q37137404-02A9185D-52F0-4A18-8D3E-FF83FD55BD0E Q37239555-B541B446-A4E3-49B5-89FF-93B70335CCF3 Q37273315-2C96989C-6D4B-4BDB-B3E4-C1C97AB7E27D Q37398065-7EF6A082-A713-42A2-B435-A958A88133F6 Q37415070-1546F927-60B6-4B94-921C-6C573C9DDC13 Q38101679-F72F154F-A98A-492F-A713-82DCB70EDD65 Q38206816-008FD25A-54AD-4494-8B1B-F1DB2A614551 Q38435747-080E7A92-33B3-4831-9F96-13A9ECF69601 Q38714821-008702B9-C995-42FA-810D-8F829E403392 Q39458843-24F27048-351E-4529-AA12-34156A27E8D3 Q40043509-CBA15D04-7AD4-4ADF-89B9-23791F9756AA Q41838051-60E80B6C-0A13-4822-B63E-EBE1A8B5C789 Q41851271-0842E740-9681-42B6-8DBC-1D1F7849890F Q42011891-AA1A7745-F674-4C2F-984F-1CAFBCFF2ED8 Q42145055-7DE22163-A880-4815-BF67-C88A95CC2C0B Q42348082-71070C73-5027-47EF-B14C-BCD2BCE5FB20 Q47211573-7E55DBA2-B16B-494E-B64A-64EFFC392F1F Q49715023-60DB8D7B-4CE4-4F6B-A773-CFD18C00B8FE

P2860

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

http://www.wikidata.org/entity/Q46917393

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@en

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@nl

type

label

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@en

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@nl

prefLabel

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@en

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@nl

P1433

Q46917393-9DDD7677-71E7-41B2-9DA8-F8C709402E2B

P1476

Q46917393-DF96D404-1295-49DF-9917-8C3E1D5DD1A3

P2093

Q46917393-01231B4F-9E93-4D02-9CC5-84C98ABA69F9

Q46917393-102F820B-15DA-434C-938B-75B984E39735

Q46917393-21DEEDB3-0434-4382-9A5D-4C01D7BC3DC4

Q46917393-48F7E4C9-2A7F-4ED5-8AE4-349C3D84CD13

Q46917393-6080EF49-13E5-475F-9637-4AFDECA76C66

Q46917393-AB404B72-555A-41BC-98F3-D6E5CF308451

Q46917393-E5EFB8BC-E094-44A6-A64E-045CD223C1E2

P2860

Q46917393-0683C98C-A298-4EB5-82D1-6A5E6D2EC142

Q46917393-07439136-8674-4B6D-8691-782E699D191F

Q46917393-1B93AF3F-B8F8-4D12-A250-7CD2288E1DB1

Q46917393-1C7877DE-B30B-4F6C-8233-E6C76CF83288

Q46917393-1C9A1D87-6AF9-42DD-BEAF-75B196BB881B

Q46917393-3A7D71B4-3279-40A4-8B5D-BE48F553F696

Q46917393-500886A7-9D62-42A2-8C77-DD71AB9587B3

Q46917393-501DBD45-4D31-45E7-9BEE-79619D220A67

Q46917393-56A46CBD-637E-48F7-A9E0-3BEAA172C3E8

Q46917393-5E2368F6-8C78-4F42-BD6D-F7E8BCDC3F3C

P2888

Q46917393-31CBAD28-9F86-4FC6-B964-3B1D18E1C0CE

P304

Q46917393-1D3EB0BF-E028-4126-8058-F9369B91A37A

P31

Q46917393-D8CD76AF-E179-47E6-8B8F-4E472138652D

P356

Q46917393-EF6F4517-7B94-4A5C-B90F-474908DA26B4

P407

Q46917393-8991A61A-A604-420C-8E6B-7CEBC08FE1A2

P433

Q46917393-A346A052-63E1-4788-AC9B-6B912FB3E5E3

P478

Q46917393-6F038B1B-5F16-44FB-BF42-297B420917BB

P50

Q46917393-D6802314-A8A2-424A-A2EE-EA58C9BE02DB

P577

Q46917393-288179BF-158D-4CBA-905D-B58A2B09E043

P698

Q46917393-F54D9D2A-F35F-4BBB-8E43-C7E558E2C049

P356

P1433

Nature Medicine

P1476

Autoimmunity and tumor immunity induced by immune responses to mutations in self.

@en

P2093

Alan N Houghton

http://www.w3.org/2001/XMLSchema#string

Andrea T Hooper

http://www.w3.org/2001/XMLSchema#string

Barry J Kappel

http://www.w3.org/2001/XMLSchema#string

Gabriele Noffz

http://www.w3.org/2001/XMLSchema#string

José A Guevara-Patiño

http://www.w3.org/2001/XMLSchema#string

Manuel E Engelhorn

http://www.w3.org/2001/XMLSchema#string

Olivia Lou

http://www.w3.org/2001/XMLSchema#string

P2860

IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex

Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.

Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas.

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

Rules for making human tumor cells.

Protection against mycoplasma infection using expression-library immunization.

P2888

P304

198-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1363

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16444264

http://www.w3.org/2001/XMLSchema#string